Evaluation and Management of Ferritin 700 µg/L with Elevated EBV IgG/EBNA and Negative IgM in an Older Adult with Fatigue
Primary Recommendation
This serologic pattern—elevated EBV IgG and EBNA with negative IgM—indicates remote EBV infection, not active disease, and the ferritin elevation of 700 µg/L requires immediate measurement of fasting transferrin saturation to distinguish true iron overload from secondary causes such as inflammation, liver disease, or metabolic syndrome. 1, 2
Understanding the EBV Serology
Interpretation of the EBV Pattern
The combination of positive EBV VCA IgG, positive EBNA-1 IgG, and negative VCA IgM is the classic serologic signature of past EBV infection, typically occurring months to years after primary infection. 3, 4
This pattern does NOT indicate acute infection, recent reactivation, or chronic active EBV disease; it simply confirms prior exposure to EBV, which is present in >90% of adults worldwide. 3, 4
EBV serology has minimal clinical utility in evaluating chronic fatigue in older adults, as multiple studies demonstrate no meaningful correlation between EBV antibody patterns and fatigue symptoms in immunocompetent patients. 5
When EBV Might Be Relevant
Chronic active EBV disease (CAEBV) requires an EBV DNA load ≥10,000 IU/mL in whole blood plus confirmation of EBV-infected T or NK cells—not just elevated antibodies—and typically presents with fever, lymphadenopathy, hepatosplenomegaly, and cytopenias, not isolated fatigue. 6
In the absence of these systemic inflammatory features, the EBV serology is incidental and unrelated to the patient's fatigue. 5, 6
Diagnostic Approach to Ferritin 700 µg/L
Step 1: Measure Transferrin Saturation Immediately
Order a fasting transferrin saturation (TS) test; this single test determines whether the elevated ferritin reflects true iron overload (TS ≥45%) or secondary hyperferritinemia (TS <45%). 1, 2
Ferritin alone cannot distinguish between iron overload and inflammation, as ferritin is an acute-phase reactant that rises during infection, liver disease, malignancy, and tissue injury independent of iron stores. 1, 2
Step 2A: If Transferrin Saturation ≥45%
Suspect primary iron overload and immediately order HFE genetic testing for C282Y and H63D mutations to diagnose hereditary hemochromatosis. 1, 2
C282Y homozygosity or C282Y/H63D compound heterozygosity confirms HFE-related hemochromatosis and warrants therapeutic phlebotomy. 1, 2
At ferritin 700 µg/L with TS ≥45%, liver biopsy is NOT required if liver enzymes are normal and the patient is <40 years old, as ferritin <1,000 µg/L has a 94% negative predictive value for advanced fibrosis. 1
Step 2B: If Transferrin Saturation <45%
Iron overload is excluded with >90% certainty, and the ferritin elevation reflects secondary causes. 1, 2
Evaluate for the most common causes of secondary hyperferritinemia:
- Chronic alcohol consumption: Obtain a detailed alcohol history; alcohol downregulates hepcidin and increases iron absorption while causing hepatocellular injury. 1, 7
- Non-alcoholic fatty liver disease (NAFLD)/metabolic syndrome: Check liver enzymes (ALT, AST), assess for obesity, diabetes, and dyslipidemia. 1, 2
- Chronic inflammation: Measure CRP and ESR to detect occult inflammatory conditions. 1, 2
- Liver disease: Order abdominal ultrasound to evaluate for fatty liver, chronic liver disease, or hepatomegaly. 1
In older adults with fatigue and ferritin 700 µg/L, NAFLD and metabolic syndrome are the most likely culprits, especially if TS <45% and liver enzymes are mildly elevated. 1, 2
Management Strategy
If TS <45% (Most Likely Scenario)
Treat the underlying condition, not the ferritin number itself. 1, 2
For NAFLD/metabolic syndrome: Recommend weight loss (target 7–10% body weight), increased physical activity, and control of diabetes and dyslipidemia. 1
For chronic alcohol use: Counsel complete abstinence; ferritin and liver enzymes typically normalize within 2–6 weeks of sustained abstinence. 7
Phlebotomy is NOT indicated when TS <45%, as the ferritin elevation does not represent iron overload. 1, 2
If TS ≥45%
Initiate therapeutic phlebotomy if HFE genetic testing confirms C282Y homozygosity or compound heterozygosity. 1
Screen first-degree relatives for hereditary hemochromatosis with TS and ferritin testing. 1
Addressing the Fatigue
Comprehensive Fatigue Workup
The EBV serology does not explain the fatigue; a broader evaluation is required. 5
Order the following tests to identify treatable causes of fatigue in older adults:
- Complete blood count (CBC) to assess for anemia or hematologic malignancy. 1
- Thyroid-stimulating hormone (TSH) to exclude hypothyroidism.
- Comprehensive metabolic panel (CMP) to evaluate renal and hepatic function.
- Vitamin B12 and folate levels.
- Hemoglobin A1c to screen for diabetes.
- Creatine kinase (CK) to evaluate for muscle necrosis. 1
Screen for depression and sleep disorders, which are common and treatable causes of fatigue in older adults.
When to Consider Specialist Referral
Refer to hepatology if:
Refer to hematology if:
Critical Pitfalls to Avoid
Do not attribute the fatigue to EBV based solely on elevated IgG and EBNA antibodies; this pattern reflects remote infection, not active disease. 3, 4, 5
Do not order EBV DNA PCR or pursue chronic active EBV disease workup unless the patient has fever, lymphadenopathy, hepatosplenomegaly, and cytopenias. 6
Do not diagnose iron overload based on ferritin alone; transferrin saturation must be measured concurrently. 1, 2
Do not order HFE genetic testing when TS <45%, as this leads to misdiagnosis and unnecessary phlebotomy. 1
Do not overlook liver biopsy if ferritin >1,000 µg/L with abnormal liver tests, as this combination predicts cirrhosis in 80% of C282Y homozygotes. 1